Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $4.05 +0.75%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 21 | New: 22
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 21 | New: 22
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $5.00 (from $7.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Cantor Fitzgerald Downgrades DOMO (DOMO) to Neutral
- Crown Castle (CCI) PT Lowered to $96 at Bernstein SocGen Group
- AMD (AMD) PT Raised to $685 at Benchmark on Microsoft, Anthropic Deals
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
